AG
GILD icon

AmeriFlex Group’s Gilead Sciences GILD Stock Holding History

AmeriFlex Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$141K Buy
1,119
+55
+5% +$7.25K 0.06% 276
2026
Q1 		$148K Sell
1,064
-176
-14% -$24.6K 0.08% 215
2025
Q4 		$152K Sell
1,240
-1,240
-50% -$151K 0.08% 209
2025
Q3 		$275K Buy
2,480
+1,192
+93% +$135K 0.1% 164
2025
Q2 		$139K Sell
1,288
-1,640
-56% -$175K 0.07% 218
2025
Q1 		$328K Buy
2,928
+207
+8% +$21.4K 0.13% 155
2024
Q4 		$264K Buy
+2,721
New +$245K 0.12% 160

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AmeriFlex Group's GILD Position: Q2 2026 in Review

AmeriFlex Group increased its Gilead Sciences (GILD) stake by 5.2% in Q2 2026, buying an estimated $7.25K and bringing the position to 1,119 shares worth $141K. The position accounts for 0.06% of the portfolio, ranked #276.

AmeriFlex Group first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $328K in Q1 2025. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • AmeriFlex Group held 1,119 shares of Gilead Sciences worth $141K as of Q2 2026.
  • AmeriFlex Group bought 55 Gilead Sciences shares in Q2 2026, an estimated $7.25K.
  • Gilead Sciences made up 0.06% of AmeriFlex Group's portfolio in Q2 2026, its #276 holding.
  • AmeriFlex Group first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • AmeriFlex Group's Gilead Sciences position peaked at $328K in Q1 2025.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on AmeriFlex Group's 13F filing for Q2 2026, filed 14 Aug 2026.